[Chylous ascites, chylothorax, and intra-osseous capillary ectasia].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001201:Ascites / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D001847:Bone Diseases / Q000150:complications* / Q000000981:diagnostic imaging; D002196:Capillaries / Q000473:pathology; D002675:Child, Preschool; D002913:Chyle / Q000032:analysis; D002916:Chylothorax / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D005260:Female; D005269:Femur / Q000000981:diagnostic imaging; D005334:Fever / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007422:Intestines / Q000098:blood supply / Q000473:pathology; D008168:Lung / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008200:Lymphangiectasis / Q000150:complications / Q000473:pathology; D008643:Mesentery / Q000473:pathology; D010014:Osteolysis / Q000150:complications; D011859:Radiography; D012272:Ribs / Q000000981:diagnostic imaging; D018805:Sepsis / Q000150:complications
D000900:Anti-Bacterial Agents
Ascite chyleuse, chylothorax et ectasies capillaires intra-osseuses